While controlling for age, sex and APOE ε4 genotype, higher CSF levels of TMAO were detected in AD and mild cognitive impairment patients compared to healthy controls suggesting the potential involvement of TMAO in AD (Vogt et al., 2018). This evidence concerns the gene APOE and Alzheimer disease.